Achtman M. .2008 .Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annual review of microbiology, : .
Bassili A.,Seita A.,Baghdadi S.,AlAbsi A.,Abdilai I.,Agboatwalla M.,Enarson D. A. Diagnostic .2008 .and treatment delay in tuberculosis in 7 countries of the Eastern Mediterranean Region. Infectious Diseases in Clinical Practice, (1) : 23-35.
Rook G. A.,Bloom B. R. . .Mechanisms of pathogenesis in tuberculosis. , 1994 : 485-501.
Boehme C. C.,Nabeta P.,Hillemann D.,Nicol M. P.,Shenai S.,Krapp F.,Perkins F. .2010 .Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine, (11) : 1005-1015.
Casemore D. P.,Armstrong M.,Sands R. L. .1985 .Laboratory diagnosis of cryptosporidiosis. Journal of Clinical Pathology, (12) : 1337-1341.
.2006 .Promising drugs against tuberculosis. Recent Patents on Anti-Infective Drug Discovery, (1) : 33-44.
Gilani S. I.,Khurram M. . .Perception of tuberculosis in Pakistan: findings of a nation-wide survey. Age (Years) 2012, 30(965) : 35.
Govender V. S.,Ramsugit S.,Pillay M. .2014 .Mycobacterium tuberculosis adhesins: potential biomarkers as anti-tuberculosis therapeutic and diagnostic targets. Microbiology, (9) : 1821-1831.
Hobby G. L.,Lenert T. F. .1968 .The antimycobacterial activity of rifampin. American Review of Respiratory Disease, (4) : 713-714.
Horsburgh C. R. .2004 .Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine, (20) : 2060-2067.
Jasmer R. M.,Nahid P.,Hopewell P. .2002 .Latent tuberculosis infection. New England Journal of Medicine, (23) : 1860-1866.
Laifangbam S.,Singh H. L.,Singh N. B.,Devi K. M.,Singh N. T. .2009 .A comparative study of fluorescent microscopy with Ziehl-Neelsen staining and culture for the diagnosis of pulmonary tuberculosis. KathmanduUniversity Medical Journal, (3) : 226-230.
Maggi N.,Arioli V.,Sensi P.,Rifamycins P. . .NSubstituted Aminomethyl Derivatives of Rifamycin SV2. Journal of medicinal chemistry, 1965, 8(6) : 790-793.
Marlowe E. M.,Novak-Weekley S. M.,Cumpio J.,Sharp S. E.,Momeny M. A.,Babst A.,Pandori M. .2011 .Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. Journal of clinical microbiology, (4) : 1621-1623.
Murray C. J. L.,Salomon J. A. .1998 .Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding [. The Pittsfield Lecture]. The International Journal of Tuberculosis and Lung Disease, (9) : S9-S15.
Pai M.,Kalantri S.,Dheda K. . .New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert review of molecular diagnostics, 2006, 6(3) : 423-432.
Sensi P. . .History of the development of rifampin. Reviews of infectious diseases, 5(Supplement_3), : S402-S406.
Shet A. .2012 .Tuberculosis in the days of yore. Pediatric Infectious Disease, (2) : 43-44.